BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6451569)

  • 1. [Biliary excretion of mezlocillin].
    Rösch W; Stock KP; Burkhardt F
    Fortschr Med; 1981 Jan; 99(3):76-8. PubMed ID: 6451569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative biliary excretion of mezlocillin and 12 other beta-lactam antibiotics (author's transl)].
    Comte F; Brogard JM; Kopferschmitt J; Dorner M; Lavillaureix J
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):353-60. PubMed ID: 6460975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental and clinical study of the biliary elimination of mezlocillin (author's transl)].
    Brogard JM; Kopferschmitt J; Dorner M; Lavillaureix J
    Pathol Biol (Paris); 1981 Sep; 29(7):405-10. PubMed ID: 6457274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary excretion of mezlocillin in patients with hepatic disease.
    Hildebrandt R; Gundert-Remy U; Raedsch R; Sieg A; Stiehl A
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):384-7. PubMed ID: 7582392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of biliary decompression on antibiotic biliary excretion.
    Yamamoto S; Kubota Y; Takaoka M; Ogura M; Tsuji K; Yanagitani K; Shimatani M; Shibatani N; Imai Y; Takamidoh S; Inoue K
    Hepatogastroenterology; 2002; 49(44):330-4. PubMed ID: 11995444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary elimination of mezlocillin: an experimental and clinical study.
    Brogard JM; Kopferschmitt J; Arnaud JP; Dorner M; La Villaureix J
    Antimicrob Agents Chemother; 1980 Jul; 18(1):69-76. PubMed ID: 6448023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biliary excretion and pharmacokinetics of mezlocillin in jaundiced patients with external bile drainage.
    Dooley JS; Gooding A; Hamilton-Miller JM; Brumfitt W; Sherlock S
    Liver; 1983 Aug; 3(4):201-6. PubMed ID: 6672502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacterial elimination and antibiotic concentration in the gall-bladder during biliary tract infections treated with mezlocillin (author's transl)].
    Helm EB; Wurbs D; Gundlach H; Beyer B; Hagenmüller F; Stille W
    Dtsch Med Wochenschr; 1981 Aug; 106(35):1087-90. PubMed ID: 6455282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of biliary tract infections (XXIV). Biliary excretion and gallbladder tissue levels of mezlocillin].
    Kobayashi N; Tanimura H; Huang WF; Sekiya T; Takahashi H; Sato T; Yoshida K; Hikasa Y
    Jpn J Antibiot; 1984 Apr; 37(4):597-604. PubMed ID: 6471380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bile composition and antibiotic excretion. Observations with T-drainage].
    Rosenthal RJ; Steigerwald SD; Bockhorn H
    Z Gesamte Inn Med; 1993 Jan; 48(1):18-22. PubMed ID: 8095119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonlinear mezlocillin kinetics due to dose-dependent metabolism.
    Gundert-Remy U; Hildebrandt R; Stiehl A; Weber E
    Clin Pharmacol Ther; 1983 May; 33(5):656-62. PubMed ID: 6220858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Penetration of mezlocillin into bronchial secretions (author's transl)].
    Morel C; Benard Y; Vergnaud M; Langeard M
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):365-7. PubMed ID: 6460977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].
    Verbist L; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):347-52. PubMed ID: 6460974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of mezlocillin in patients with biliary t-tube drainage.
    Gundert-Remy U; Förster D; Schacht P; Weber E
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():65-75. PubMed ID: 6210684
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of mezlocillin in open heart surgery (author's transl)].
    Kalmar P; Krebber HJ; Müller-Schwefe C; Malerczyk V; Wolf W
    Herz; 1980 Oct; 5(5):314-9. PubMed ID: 6450151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of acylureidopenicillin pharmacokinetics.
    Bergan T
    Scand J Infect Dis Suppl; 1981; 29():33-48. PubMed ID: 7031864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic studies on the penetration of azlocillin and mezlocillin into bone and tissue fluid (author's transl)].
    Wittmann DH; Schassan HH; Seidel H
    Arzneimittelforschung; 1981; 31(7):1157-62. PubMed ID: 6456009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies on the biliary excretion of mezlocillin, especially in cases with liver dysfunction].
    Maeba T; Hashimoto T; Takeda T; Shiraishi Y; Oike H; Wakabayashi H; Omori G; Indo S; Kunikata E; Hayashi M
    Jpn J Antibiot; 1986 Jan; 39(1):116-20. PubMed ID: 3702053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of intramuscular mezlocillin in patients with normal and impaired renal function (author's transl)].
    Brogard JM; Comte F; Kopferschmitt J; Dorner M; Lavillaureix
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):340-6. PubMed ID: 6460973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of biliary bile acid output to hepatic adenosine triphosphate level and biliary indocyanine green excretion in humans.
    Chijiiwa K; Mizuta A; Ueda J; Takamatsu Y; Nakamura K; Watanabe M; Kuroki S; Tanaka M
    World J Surg; 2002 Apr; 26(4):457-61. PubMed ID: 11910480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.